Status: current, Defined. Date: 31-Jan 2016. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3853281000168116 | Jardiamet 5 mg/500 mg (empagliflozin 5 mg + metformin hydrochloride 500 mg) tablet, 60 tablets, blister pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3853291000168118 | Jardiamet 5 mg/500 mg tablet, 60, blister pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Jardiamet 5 mg/500 mg tablet, 60, blister pack | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Jardiamet 5 mg/500 mg tablet, 60, blister pack | Is a | Jardiamet 5 mg/500 mg tablet, 60 | true | Inferred relationship | Some | ||
| Jardiamet 5 mg/500 mg tablet, 60, blister pack | has TPUU | Jardiamet 5 mg/500 mg tablet | true | Inferred relationship | Some | 1 | |
| Jardiamet 5 mg/500 mg tablet, 60, blister pack | has container type | blister pack | true | Inferred relationship | Some | ||
| Jardiamet 5 mg/500 mg tablet, 60, blister pack | has TP | Jardiamet 5 mg/500 mg | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Description inactivation indicator reference set
Containered trade product pack reference set
FHIR